Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
[Special cases of multiple sclerosis].
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients.
Pathology of multiple sclerosis: where do we stand?
Paroxysmal ataxia and dysarthria in multiple sclerosis.
The HLA region in multiple sclerosis.
Management of bladder dysfunction in patients with multiple sclerosis.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
[Clinical features of neuromyelitis optica and the distribution of Chinese medical syndrome types: a case report of 63 cases].
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
The organization of the sphingosine 1-phosphate signaling system.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Post trauma vision syndrome and visual midline shift syndrome.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »